Leading pharmaceutical company in CNS seeks startups to improve performance of clinical trials.
DxLab Inc. (DxLab) is a biotech startup, spun out of MIT and Harvard in September 2020, developing and commercializing a next-generation point-of-care (POC) diagnostic solution for rapid, on-site detection of dangerous pathogens. Combining proprietary platform technology with novel target detection and signal processing methods, we are advancing a pipeline of rapid POC tests.
P&G is looking for partners and solutions that can support the automation of quality testing and preparation process at its Feminine Care manufacturing sites.
Vincent Ling, Senior Director, Materials and Innovation, Takeda
Applications deadline: November 1